NOW ENROLLINGPHASE 3

Food allergy study

A study for people living with peanut, milk, or egg allergy, testing an oral medication under full medical supervision.

PHASEPhase 3
LENGTH52 weeks
VISITSIn-person visits + supervised food challenges
AGE12 to 65
Overview

About this study

We are conducting a clinical trial to see if an oral study medicine can help people with peanut, milk, or egg allergy better tolerate accidental exposure to their food allergen. Participants receive specialist care at no cost throughout the study.

Eligibility

Who can take part

Timeline

What to expect

1

Screening

Up to 6 weeks. We confirm eligibility through allergy testing and a supervised food challenge in our clinic.

2

Treatment period 1

Up to 24 weeks. Daily oral study medication and regular clinic visits.

3

Treatment period 2

All participants continue on the active study medication through week 52.

4

Follow-up

4-week safety check-in after the end of treatment.

The study medicine

The study medicine is an oral pill taken twice daily. It is being investigated for its ability to reduce the severity of allergic reactions to food allergens. All allergy testing and supervised oral food challenges happen under medical supervision in our clinic with full safety monitoring.

Placebo and assignment

During the first part of the study, participants are randomly assigned to receive either the active study medication or a placebo. During the second part, all participants receive the active study medication.

Self-check

See if this study might fit you

A quick check you run on your own device. Your answers are never sent, saved, or tracked - only our research team asks screening questions, by phone, privately.

Next step

Ask about this study

Leave your contact details and a research coordinator will reach out within two business days. Or call us directly at 437-317-1991.

Please do not include personal health details here. Our research team collects anything needed by phone, privately.